[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100647884":3},{"organization":4,"armGroups":7,"interventions":27,"overallOfficials":37,"centralContacts":41,"locations":45,"responsibleParty":68,"collaborators":33,"id":70,"slug":71,"hasResults":72,"nctId":73,"briefTitle":74,"officialTitle":75,"acronym":33,"eligibilityCriteria":76,"healthyVolunteers":77,"sex":78,"minAge":79,"maxAge":80,"enrollmentInfo":81,"targetDuration":33,"studyType":84,"phases":85,"briefSummary":87,"conditions":88,"keywords":90,"overallStatus":48,"whyStopped":33,"lastUpdateSubmitDate":93,"lastUpdatePostDateStruct":94,"startDateStruct":97,"completionDateStruct":99,"leadSponsor":101,"locationsCount":102},{"fullName":5,"class":6},"Xencor, Inc.","INDUSTRY",[8,14,20,24],{"label":9,"type":10,"description":11,"interventionNames":12},"Part A: Active Drug","ACTIVE_COMPARATOR","Active XmAb412 to be administered to healthy adult participants.",[13],"Drug: XmAb412 Monoclonal Bispecific Antibody",{"label":15,"type":16,"description":17,"interventionNames":18},"Part A: Placebo","PLACEBO_COMPARATOR","Placebo Comparator to be administered to healthy participants.",[19],"Drug: Placebo",{"label":21,"type":10,"description":22,"interventionNames":23},"Part B: Active","Active XmAb412 to be administered to healthy participants.",[13],{"label":25,"type":16,"description":17,"interventionNames":26},"Part B: Placebo",[19],[28,34],{"type":29,"name":30,"description":31,"armGroupLabels":32,"otherNames":33},"DRUG","XmAb412 Monoclonal Bispecific Antibody","Monoclonal Bispecific Antibody",[9,21],null,{"type":29,"name":35,"description":35,"armGroupLabels":36,"otherNames":33},"Placebo",[15,25],[38],{"name":39,"affiliation":5,"role":40},"412 Study Information","STUDY_DIRECTOR",[42],{"name":39,"role":43,"phone":33,"phoneExt":33,"email":44},"CONTACT","XmAb412-01info@xencor.com",[46,60],{"facility":47,"status":48,"city":49,"state":50,"zip":51,"country":52,"countryCode":53,"cosmosGeoPoint":54,"geoPoint":59,"contacts":33},"Xencor Investigative Site","RECRUITING","Joondalup","Western Australia","6027","Australia","AU",{"type":55,"coordinates":56},"Point",[57,58],115.76835,-31.74445,{"lat":58,"lon":57},{"facility":47,"status":48,"city":61,"state":50,"zip":62,"country":52,"countryCode":53,"cosmosGeoPoint":63,"geoPoint":67,"contacts":33},"Nedlands","6009",{"type":55,"coordinates":64},[65,66],115.8073,-31.98184,{"lat":66,"lon":65},{"type":69,"investigatorFullName":33,"investigatorTitle":33,"investigatorAffiliation":33,"oldNameTitle":33,"oldOrganization":33},"SPONSOR","100647884","phase-1-study-of-xmab412-in-healthy-participants-100647884",false,"NCT07713485","Study of XmAb412 in Healthy Participants","A Phase 1, First-in-human, Randomized, Double-blind, Placebo-controlled, Single and Multiple-dose Escalation Trial to Evaluate Safety, Tolerability, and Pharmacokinetics of XmAb412 in Healthy Adult Participants","Inclusion Criteria:\n\n* Age 18-55 years old\n* Must be in good health with no significant medical history\n* BMI 18-35 kg\u002Fm2\n* Contraceptive use consistent with local regulations\n* Able and willing to provide written informed consent\n\nExclusion Criteria:\n\n* Any physical condition that prohibits study completion\n* Known hypersensitivity to the trial intervention or any of its components\n* HIV, hepatitis B and hepatitis C positive\n* Clinically significant abnormal ECG\n* Use of other investigational products within 5 half lives from Screening\n* Blood or plasma donation within 60 days from Screening\n* Pregnant or breastfeeding\n\nOther protocol defined inclusion\u002Fexclusion criteria apply",true,"ALL","18 Years","55 Years",{"count":82,"type":83},128,"ESTIMATED","INTERVENTIONAL",[86],"PHASE1","This Phase 1 Study will evaluate the safety, tolerability, pharmacokinectics and pharmacodynamics of XmAb412 in healthy adult participants",[89],"Not Applicable - Healthy Adult Participants",[91,92],"Inflammatory Bowel Disease","Health Adult Participants","2026-07-31",{"date":95,"type":96},"2026-08-03","ACTUAL",{"date":98,"type":96},"2026-07-13",{"date":100,"type":83},"2028-03",{"name":5,"class":6},2]